Skip to content

Total debt at other companies

IAR
Integra LifeSciencesIART
$1.98B+3.2%
Artivion logo
ArtivionAORT
$258.16M-28.8%
Solventum logo
SolventumSOLV
$5.79B-26.8%
Vericel logo
VericelVCEL
$95.04M-4.6%
Enovis logo
EnovisENOV
$1.35B-3.1%
Tactile Systems Technology logo
Tactile Systems TechnologyTCMD
$15.17M-62.7%

Other financials

Income statement

See full
Revenue$59.0M-33.1%
Gross profit$41.6M-41.9%
Operating income-$16.0M-295%
Net income-$10.9M-255%
EPS (diluted)-$0.07-240%

Balance sheet

See full
Cash & equivalents$159.8M+50.1%
Total equity$242.9M+19.8%
Total assets$308.7M+14.1%

Cash flow

See full
Operating cash flow$1.9M-64.5%
CapEx$570.0K+51.2%
Free cash flow$1.3M-73.4%

Valuation

See full
Market cap$567.48M-33.9%
Enterprise value$425.3M-44.8%
P/E18.5×-2.9×
P/S1.5×-1.0×

Profitability

See full
Gross margin81%-0.9pp
Operating margin10.2%-5.1pp
Net margin7.9%-3.5pp
FCF margin17.8%-0.5pp

Returns & leverage

See full
Return on equity13.8%-8.6pp
Debt / equity0.1×0.0×
Current ratio5.4×+0.7×

Where this comes from

Calculated from MiMedx Group’s reported figures.

The official record: MiMedx Group’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about MiMedx Group's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MiMedx Group's total debt?
MiMedx Group (MDXG) reported total debt of $17.59M in Q1 2026.
How has MiMedx Group's total debt changed year-over-year?
MiMedx Group's total debt decreased by 5.7% year-over-year, from $18.66M to $17.59M.
What is the long-term trend for MiMedx Group's total debt?
Over 5 years (2020 to 2025), MiMedx Group's total debt has grown at a -15.3% compound annual growth rate (CAGR), from $51.83M to $22.53M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.